For the first time, researchers had a tool that could stimulate GH without confounding hormonal changes allowing cleaner experimental designs and more interpretable results
As federal regulators intensify scrutiny of compounded GLP-1 drugs and telehealth marketing practices, two developments in early March 2026 signal a turning point for the industry: a wave of FDA enforcement actions and a high-profile resolution between Hims & Hers Health and Novo Nordisk
Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.
Our semaglutide diet plan guide covers nutrition strategies that minimize digestive discomfort while maintaining adequate nutrition
Availability of data and materials Data supporting the findings of this study are available from the corresponding author upon reasonable request by a qualified researcher and upon approval by the data-clearing committee of the Medical University Vienna
This is not listed on the label but is one of the most clinically significant aspects of these medications